Skip to main content

ResMed| cash flow statement

  • RMD · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$239.53+0.27%Close 13 Nov 2026 · Market value $33.91B

In fiscal 2026 (the year to 30 Jun 2026), ResMed| generated $1.81B of operating cash flow and $1.65B of free cash flow, after $156.3M of capital expenditure.

From ResMed|'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 30 Jun 2026. TTM is the last four reported quarters added up.

Annual

ResMed| cash flow statement, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026TTM
Net income$146.4M$190.1M$227.0M$254.8M$307.1M$345.3M$352.9M$352.4M$342.3M$315.6M$404.6M$621.7M$474.5M$779.4M$897.6M$1.02B$1.40B$1.52B$1.59B
Depreciation & amortization$53.96M$61.56M$70.62M$85.86M$78.28M$73.45M$73.06M$86.85M$112.2M$120.0M$150.8M$154.8M$156.8M$159.6M$165.2M$176.9M$198.5M$201.3M$195.4M
Stock-based compensation$25.52M$29.73M$30.81M$30.59M$38.16M$43.46M$47.85M$46.41M$45.92M$48.41M$52.07M$57.56M$63.93M$65.26M$71.14M$80.18M$91.66M$104.3M$112.7M
Operating cash flow$238.9M$188.2M$283.2M$383.2M$402.8M$391.3M$383.2M$547.9M$414.1M$505.0M$459.1M$802.3M$736.7M$351.1M$693.3M$1.40B$1.75B$1.81B$1.77B
Operating cash flow margin25.9%17.2%22.8%28.0%26.6%25.2%22.8%29.8%20.0%21.6%17.6%27.1%23.0%9.8%16.4%29.9%34.0%31.9%30.9%
Capital expenditures$109.7M$56.85M$66.61M$47.13M$63.58M$72.72M$62.50M$58.53M$62.22M$62.58M$68.71M$95.33M$102.7M$134.8M$119.7M$99.46M$89.86M$156.3M$162.1M
Acquisitions$2.39M$10.66M$22.45M$53.32M$5.42M$3.85M$29.41M$1.04B$7.27M$902.0K$951.4M$27.91M$39.07M$42.78M$1.01B$133.5M$139.2M$350.7M$357.7M
Free cash flow$129.2M$131.4M$216.6M$336.0M$339.2M$318.5M$320.7M$489.4M$351.8M$442.4M$390.3M$706.9M$634.0M$216.3M$573.6M$1.30B$1.66B$1.65B$1.61B
Free cash flow margin14.0%12.0%17.4%24.6%22.4%20.5%19.1%26.6%17.0%18.9%15.0%23.9%19.8%6.0%13.6%27.8%32.3%29.2%28.1%
Free cash flow per share$0.84$0.85$1.38$2.25$2.32$2.21$2.25$3.45$2.47$3.07$2.70$4.85$4.33$1.47$3.89$8.82$11.28$11.29$11.08
Dividends paid————$97.20M$141.5M$157.3M$168.1M$186.3M$199.5M$211.7M$225.1M$226.7M$245.3M$258.3M$282.3M$310.9M$349.7M$356.9M
Gross share repurchases$68.59M$131.1M$163.3M$392.7M$186.3M$202.2M$160.3M$102.1M—$53.80M$22.84M——$0.00$0.00$150.0M$300.0M$700.0M$1.49B
Stock issuance proceeds$24.89M$95.22M$94.65M$62.49M$69.24M$33.35M$38.81M$27.69M$38.32M$38.72M$36.73M$48.18M$37.79M$47.38M$49.14M$53.09M$74.44M$74.50M$69.95M
Net share repurchases$43.70M$35.86M$68.69M$330.3M$117.0M$168.8M$121.5M$74.36M−$38.32M$15.08M−$13.88M−$48.18M−$37.79M−$47.38M−$49.14M$96.92M$225.6M$625.5M$1.42B
Cash interest paid$5.97M$2.67M$1.76M$4.79M$6.39M$6.13M$5.78M$11.21M$28.24M$28.36M$36.16M$40.38M$23.99M$22.31M$47.38M$45.71M$28.41M$27.06M$24.78M
Free cash flow after SBC$103.7M$101.6M$185.8M$305.4M$301.1M$275.1M$272.8M$443.0M$305.9M$394.0M$338.3M$649.4M$570.1M$151.1M$502.5M$1.22B$1.57B$1.55B$1.50B

Quarterly

ResMed| cash flow statement, quarterly
USDQ2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Net income$208.8M$300.5M$292.2M$311.4M$344.6M$365.0M$379.7M$348.5M$392.6M$398.7M$383.4M$418.4M
Depreciation & amortization$44.78M$43.47M$43.68M$44.73M$46.44M$43.67M$63.63M$47.70M$49.88M$58.98M$44.78M$41.74M
Stock-based compensation$19.84M$20.44M$21.39M$20.16M$22.63M$24.12M$24.75M$21.16M$28.94M$26.79M$27.46M$29.48M
Operating cash flow$272.8M$402.0M$440.1M$325.5M$308.6M$578.7M$538.8M$457.3M$339.7M$554.1M$454.6M$422.4M
Operating cash flow margin23.5%33.6%36.0%26.6%24.1%44.8%40.0%34.2%23.9%38.7%31.1%29.9%
Capital expenditures$23.35M$21.19M$24.88M$17.84M$20.64M$20.80M$30.59M$42.97M$28.54M$33.65M$51.13M$48.74M
Acquisitions$7.50M$3.08M$19.70M$0.00$670.0K$0.00$138.6M$522.0K$0.00$24.88M$325.3M$7.49M
Free cash flow$249.5M$380.8M$415.2M$307.7M$288.0M$557.9M$508.2M$414.4M$311.2M$520.5M$403.5M$373.7M
Free cash flow margin21.5%31.8%33.9%25.1%22.5%43.2%37.7%31.0%21.9%36.4%27.6%26.4%
Free cash flow per share$1.69$2.58$2.81$2.08$1.95$3.79$3.46$2.82$2.13$3.57$2.78$2.61
Dividends paid$70.68M$70.49M$70.55M$77.89M$77.69M$77.70M$77.59M$87.75M$87.58M$87.24M$87.09M$94.95M
Gross share repurchases$50.01M$50.00M$50.00M$50.01M$74.99M$75.03M$100.0M$150.0M$175.0M$175.0M$200.0M$936.4M
Stock issuance proceeds$19.52M$4.89M$27.70M$8.38M$26.88M$9.02M$30.16M$8.21M$29.56M$7.43M$29.31M$3.65M
Net share repurchases$30.48M$45.11M$22.31M$41.62M$48.11M$66.00M$69.85M$141.8M$145.5M$167.6M$170.7M$932.7M
Cash interest paid$13.80M$11.03M$5.92M$7.35M$66.00K$14.22M$6.91M$6.85M$6.61M$6.53M$7.06M$4.58M
Free cash flow after SBC$229.6M$360.4M$393.8M$287.5M$265.3M$533.7M$483.4M$393.2M$282.3M$493.7M$376.0M$344.2M

The main figures as JSON and plain text. See data and methodology.

RMD in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.